Loxo Oncology secures Mean Deviation of 1.82 and Risk Adjusted Performance of 0.010286. In connection with Fundamental Indicators, Macroaxis technical analysis interface lets you check existing technical drivers of Loxo Oncology as well as the relationship between them. Strictly speaking you can use this information to find out if the firm will indeed mirror its model of past prices or the prices will eventually revert. We found nineteen technical drivers for Loxo Oncology which can be compared to its peers in the industry. Please verify Loxo OncologyStandard Deviation as well as the relationship between Value At Risk and Kurtosis to decide if Loxo Oncology is priced some-what accurately providing market reflects its recent price of 177.44 per share. Given that Loxo Oncology has Jensen Alpha of 0.010522, we recommend you check Loxo Oncology last-minute market performance to make sure the company can sustain itself at future point.
The output start index for this execution was fourteen with a total number of output elements of three. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Loxo Oncology volatility. High ATR values indicate high volatility, and low values indicate low volatility. View also all equity analysis or get more info about average true range volatility indicators indicator.
Loxo Oncology Trend Analysis
Use this graph to draw trend lines for Loxo Oncology. You can use it to identify possible trend reversals for Loxo Oncology as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Loxo Oncology price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.
Loxo Oncology Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Loxo Oncology applied against its price change over selected period. The best fit line has a slop of 0.25 % which means Loxo Oncology will continue generating value for investors. It has 34 observation points and a regression sum of squares at 50.8, which is the sum of squared deviations for the predicted Loxo Oncology price change compared to its average price change.
Did you try this?
Run Portfolio Manager Now
State of the art Portfolio Manager to monitor and improve performance of your invested capital